Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators.

Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5.

PMID:
21975206
2.

Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures.

Gold SM, Schulz H, Mönch A, Schulz KH, Heesen C.

Mult Scler. 2003 Aug;9(4):404-10.

PMID:
12926847
3.

Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone.

Heesen C, Bruegmann M, Gbdamosi J, Koch E, Mönch A, Buhmann C.

Mult Scler. 2003 Mar;9(2):213-4. No abstract available.

PMID:
12708818
4.

Prolactin stimulation in multiple sclerosis--an indicator of disease subtypes and activity?

Heesen C, Gold SM, Bruhn M, Mönch A, Schulz KH.

Endocr Res. 2002 Feb-May;28(1-2):9-18.

PMID:
12108793
5.

Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS).

Gold SM, Heesen C, Schulz H, Guder U, Mönch A, Gbadamosi J, Buhmann C, Schulz KH.

Mult Scler. 2001 Apr;7(2):119-30.

PMID:
11424632
6.

[The maternal and perinatal mortality and morbitity in attendance to Caesarean section in the period from 1956--1976 at the UFK-Jena (author's transl)].

Krause W, Möbius W, Günther M, Eichhorn KH, Creutzburg P, Mönch A, Knappe M, Kunath H.

Z Geburtshilfe Perinatol. 1979 Apr;183(2):136-47. German.

PMID:
442730
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk